Burzynski Research Institute Inc (BZYR)
OTHER OTC:BZYR
BZYR Stock Chart & Stats
$0.02
$0.02(60.97%)
At close: 4:00 PM EST
$0.02
$0.02(60.97%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.06
Previous CloseN/A
Volume15.70K
Average Volume (3M)9.99K
Market Cap
$1.34M
Enterprise Value$1.71M
Total Cash (Recent Filing)$2.17K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.68
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding131,448,440
10 Day Avg. Volume3,855
30 Day Avg. Volume9,993
Financial Highlights & Ratios
PEG Ratio-1.87
Price to Book (P/B)-183.11
Price to Sales (P/S)0.00
P/FCF Ratio-19.62
Enterprise Value/Market Cap1.28
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-1.03
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Burzynski Research Institute News
BZYR FAQ
What was Burzynski Research Institute Inc’s price range in the past 12 months?
Burzynski Research Institute Inc lowest stock price was <$0.01 and its highest was $0.06 in the past 12 months.
What is Burzynski Research Institute Inc’s market cap?
Burzynski Research Institute Inc’s market cap is $1.34M.
When is Burzynski Research Institute Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Burzynski Research Institute Inc’s earnings last quarter?
Currently, no data Available
Is Burzynski Research Institute Inc overvalued?
According to Wall Street analysts Burzynski Research Institute Inc’s price is currently Overvalued.
Does Burzynski Research Institute Inc pay dividends?
Burzynski Research Institute Inc does not currently pay dividends.
What is Burzynski Research Institute Inc’s EPS estimate?
Burzynski Research Institute Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Burzynski Research Institute Inc have?
Burzynski Research Institute Inc has 131,448,440 shares outstanding.
What happened to Burzynski Research Institute Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Burzynski Research Institute Inc?
Currently, no hedge funds are holding shares in BZYR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Burzynski Research Institute Inc
The Burzynski Research Institute, Inc. primarily focuses on the exploration and development of antineoplaston medications designed for cancer treatment. Beyond its research efforts, the company is actively engaged in the manufacturing, promotion, and distribution of specialized medical chemical compounds. These unique substances, known commercially as Antineoplastons, are comprised of peptides that inhibit growth, alongside amino acid derivatives and various organic acids. The institute also extends its expertise by offering consulting services. Founded in Houston, Texas, in 1977, the organization has its principal operations in that city.
Technical Analysis
Alaunos Therapeutics
―
―
Indaptus Therapeutics
―
InMed Pharmaceuticals
―
Xenetic Biosciences
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.02% Other Institutional Investors
99.98% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---